Anchiano Therapeutics Ltd ADR (ANCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ANCN | OKUR | INMB | ||
| Company | Anchiano Therapeutics Ltd ADR | Onkure Therapeutics Inc | Inmune Bio Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 5.10 | 2.64 | 1.3200 | ||
| High | 8.20 | 2.74 | 1.3400 | ||
| Low | 4.60 | 2.50 | 1.2750 | ||
| Latest | 4.71 | 2.60 | 1.3100 | ||
| Change | +0.24 | -0.04 | -0.0100 | ||
| % Change | +5.37% | -1.52% | -0.76% | ||
| Volume | 25,037,500 | 69,300 | 356,600 | ||
| 20-Day Average Volume | 4,785,015 | 99,615 | 333,030 | ||
| Previous Close | 4.47 | 2.64 | 1.3200 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 4.07 | 2.57 | 1.5255 | ||
| 20-Day Raw Stochastic | 37.68% | 37.76% | 6.67% | ||
| 20-Day Relative Strength | 56.58 | 47.00 | 37.95 | ||
| Weighted Alpha | +284.79 | -37.25 | -74.32 | ||
| Today's Opinion | 96% Buy | 40% Sell | 100% Sell | ||
| Previous Opinion | 96% Buy | 40% Sell | 100% Sell | ||
| Last Month's Opinion | 100% Buy | 32% Buy | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.92% since 03/09/21 | +7.88% since 02/12/26 | -10.88% since 02/12/26 | ||
| Low | 4.03 on 03/10/21 | 2.39 on 02/17/26 | 1.2750 on 02/20/26 | ||
| High | 8.20 on 03/16/21 | 2.76 on 02/19/26 | 1.5050 on 02/13/26 | ||
| 1-Month | |||||
| %Chg | -3.68% since 02/16/21 | -12.61% since 01/20/26 | -18.13% since 01/20/26 | ||
| Low | 2.60 on 03/04/21 | 2.23 on 02/04/26 | 1.2750 on 02/20/26 | ||
| High | 8.20 on 03/16/21 | 3.21 on 01/27/26 | 1.8000 on 01/28/26 | ||
| 3-Month | |||||
| %Chg | +79.77% since 12/16/20 | -0.76% since 11/20/25 | -12.08% since 11/20/25 | ||
| Low | 1.65 on 01/04/21 | 2.23 on 02/04/26 | 1.2750 on 02/20/26 | ||
| High | 10.55 on 02/10/21 | 3.52 on 12/08/25 | 2.3000 on 12/11/25 | ||
| 6-Month | |||||
| %Chg | +344.34% since 09/16/20 | -4.76% since 08/20/25 | -44.49% since 08/20/25 | ||
| Low | 0.91 on 10/22/20 | 2.23 on 02/04/26 | 1.2750 on 02/20/26 | ||
| High | 10.55 on 02/10/21 | 3.63 on 10/28/25 | 2.4400 on 08/22/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 34,948 | 35,225 | 34,826 | ||
| Shares Outstanding, K | 7,420 | 13,548 | 26,585 | ||
| Annual Sales | 0 | 0 | 10,000 | ||
| Annual Net Income | -11,610,000 | -52,670,000 | -42,080,000 | ||
| Last Quarter Sales | 0 | 0 | 0 | ||
| Last Quarter Net Income | -2,140,000 | -14,700,000 | -24,460,000 | ||
| 60-Month Beta | 0.95 | 0.46 | 0.72 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -1.09 on 11/06/25 | -0.24 on 10/30/25 | ||
| Latest Earnings Date | 05/06/21 | 03/09/26 | 03/26/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||